Barry Quart

Sex Difference in Risk of Torsade de Pointes With <i>d,l-</i> Sotalol

Michael H. Lehmann, S. Hardy, Donald Archibald et al. · Circulation · 1996 · 453 citations

Medicine, Cardiology, Pharmacology +17

RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer

Cory Iverson, Gary Larson, Chon Lai et al. · Cancer Research · 2009 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictors of optimal virological response to potent antiretroviral therapy

William G. Powderly, Michael S. Saag, Sharon Chapman et al. · AIDS · 1999 · 180 citations

Medicine, Pharmacology, Pharmacotherapy +17

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney

Jeffrey N. Miner, Philip K. Tan, David Hyndman et al. · Arthritis Research & Therapy · 2016 · 124 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.

James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr et al. · PubMed · 1998 · 107 citations

Medicine, Pharmacokinetics, Pharmacology +17